The messenger ribonucleic acid (mRNA) levels in cells for complement C1q and C3 components were monitored using RNA gel blot and non-radioactive in situ hybridization in the frontal cortex of AD patients and control subjects of the same age group [83]. Here, C3 is linked to Alzheimer disease.